204 results on '"Doga M"'
Search Results
2. Acromegalic osteopathy: An update
3. New medical therapies of acromegaly
4. High prevalence of radiological vertebral fractures in adult patients with Ehlers–Danlos syndrome
5. Diabetes in Cushing Disease
6. Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugs
7. Vitamin D and Glucocorticoid-Induced Osteoporosis
8. Neuroendocrinology of Bone Metabolism
9. Trattare sempre il deficit di GH nell’adulto?
10. Growth hormone deficiency in the adult
11. Cardiovascular risk in aging and obesity: Is there a role for GH?
12. Development of Graves’ hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto’s hypothyroidism
13. Bisphosphonates in the Treatment of Glucocorticoid-Induced Osteoporosis
14. REGIONAL INTRAVENOUS VERSUS SYSTEMIC INTRAVENOUS PROPHYLACTIC ADMINISTRATION IN THIRD-GENERATION CEPHALOSPORINS (CEFTAZIDIME AND CEFTRIAXONE) IN ELECTIVE FOOT SURGERY
15. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: Relevant clinical aspects
16. Exercise-induced microalbuminuria in patients with active acromegaly: Acute effects of slow-release lanreotide, a long-acting somatostatin analog
17. Vertebral fractures in males with type 2 diabetes treated with rosiglitazone
18. Prevention and treatment of glucocorticoid-induced osteoporosis
19. Diagnostic and therapeutic consensus on acromegaly
20. Clinical review: Growth hormone and cardiovascular risk factors
21. Preparing quantum many-body scar states on quantum computers
22. Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis
23. Clinical review 136: Primary lymphoma of the pituitary: an emerging clinical entity
24. Malattie Endocrine
25. Effect of acute and sustained GH inhibition with octreotide on heart rate variability in active acromegaly
26. Growth hormone autofeedback impairmed in active acromegaly
27. Benchmarking variational quantum eigensolvers for the square-octagon-lattice Kitaev model
28. Short-term effects of a single slow release lanreotide injection on cardiovascular response to exercise in patients with active acromegaly
29. Effetto a breve e a lungo termine della somministrazione di lanreotide sulla secrezione di ormone della crescita (GH) nei pazienti con acromegalia in fase attiva
30. Ambulatory blood pressure monitoring in normotensive acromegalic patients, effect of a 24 hour continuous infusion of octreotide
31. Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism
32. ALMAN DÜŞÜNCE KURULUŞU BİLİM VE SİYASET VAKFI’NIN (STİFTUNG WİSSENSCHAFT UND POLİTİK) DIŞ POLİTİKADAKİ ETKİNLİĞİ / Effectiveness Of The German Think Tank Science And Politics Foundation (Stiftung Wissenschaft Und Politik) In Foreign Policy
33. Central alpha-2 adrenergic function in patients with essential hypertension. Comparative study of growth hormone (GH) secretion stimulated by clonidine and GH-releasing hormone
34. Influence of diabetes mellitus on vertebral fractures in men with acromegaly
35. High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas
36. Ambulatory blood pressure monitoring in normotensives acromegalic patients: effects of a 24 hours continuous infusion of Octreotide
37. Prevalence of thoracic vertebral fractures in hospitalized elderly patients with heart failure
38. P-30 Growth hormone deficiency and acromegaly have comparable effects on bone mass and osteoporotic fracture risk in adult women
39. Biochemical Evaluation of Patients with Active Acromegaly and Type 2 Diabetes Mellitus: Efficacy and Safety of the Galanin Test
40. Comparison of Weed Problems in Main and Second Crop Maize (Zea mays L.) Growing Areas in Turkey
41. Effect of the GHRP-6 analog hexarelin and arginine alone and combined on GH secretion in patients with active acromegaly
42. Evaluation of the outcome of neurosurgical treatment of acromegaly: Relationship between IGF-I and growth hormone at baseline and after oral glucose tolerance test (OGTT) levels
43. Effect of Pyridostigmine on the Hydrocortisone-Mediated Decrease of Circulating Growth Hormone Levels in Acromegaly
44. Physiological role of galanin in the regulation of anterior pituitary function in humans
45. Effects of Metoclopramide on the Growth Hormone Response to Galanin in Normal Man
46. Galanin decreases circulating growth hormone levels in acromegaly.
47. Comparative Effect of Clonidine and Growth Hormone (GH)-Releasing Hormone on GH Secretion in Adult Patients on Chronic Glucocorticoid Therapy
48. Comparative Effect of Porcine and Rat Galanin on Growth Hormone Secretion in Normal Adult Men
49. Central Alpha-2 Adrenergic Function in Patients with Essential Hypertension
50. Diagnosis and treatment of acromegaly and its complications: consensus guidelines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.